GMS Infectious Diseases
Volume 3 (2015)
- Brief ReportCorrelation of (1→3)-β-D-glucan with other inflammation markers in chronically HIV infected persons on suppressive antiretroviral therapyHoenigl M, Faria de Oliveira M, Pérez-Santiago J, Zhang Y, Woods SP, Finkelman M, Gianella SGMS Infect Dis. 2015;3:Doc03 (2015-12-22)
- Research ArticleIn vitro activity of ceftobiprole against key pathogens associated with pneumonia in hospitalized patients: results from the PEG surveillance study, 2010Kresken M, Körber-Irrgang B, Kaase M, Layer F, Pfeifer Y, Werner G, Hafner D, Working Party “Antimicrobial Resistance” of the Paul Ehrlich Society for ChemotherapyGMS Infect Dis. 2015;3:Doc02 (2015-10-08)With Erratum (2015-11-03)
- Research ArticleSafety and outcome of treatment with voriconazole in a large cohort of immunocompromised children and adolescentsPieper S, Kolve H, Meine T, Goletz G, Groll AHGMS Infect Dis. 2015;3:Doc01 (2015-02-17)
 
                                                        


